Peli BioThermal Acquires Evo: Cold Chain Heats Up
Update: 2025-10-08
Description
Peli BioThermal just made a power move, acquiring Evo Cold Chain to dominate cryogenic transport for cell and gene therapies! This acquisition equips Peli with cutting-edge cryogenic shippers and real-time tracking tech, creating a one-stop shop for ultra-cold shipping solutions. As the cell and gene therapy market explodes to $93 billion by 2030, Peli BioThermal is positioning itself as a cold chain leader, ensuring the safe and precise delivery of life-saving medicines. This isn't just shipping; it's safeguarding the future of medicine.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
